Market Value3,561,179,764
Total Holdings96
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PRVA / Privia Health Group, Inc.
BLU / Bellus Health Inc
LRMR / Larimar Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ROIV / Roivant Sciences Ltd.
IOVA / Iovance Biotherapeutics, Inc.
NVNO / enVVeno Medical Corporation
IMTX / Immatics N.V.
SONX / Sonendo, Inc.
ATXS / Astria Therapeutics, Inc.
ZYME / Zymeworks Inc.
PEN / Penumbra, Inc.
ICVX / Icosavax, Inc.
TVTX / Travere Therapeutics, Inc.
SCPH / scPharmaceuticals Inc.
SRPT / Sarepta Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
HLVX / HilleVax, Inc.
ADMA / ADMA Biologics, Inc.
VRCA / Verrica Pharmaceuticals Inc.
PCVX / Vaxcyte, Inc.
SLDB / Solid Biosciences Inc.
MRTX / Mirati Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.
RVNC / Revance Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
ISO / IsoPlexis Corp
ABOS / Acumen Pharmaceuticals, Inc.
CINC / CinCor Pharma Inc
XENE / Xenon Pharmaceuticals Inc.
SAVA / Cassava Sciences, Inc. Put
CBAY / CymaBay Therapeutics, Inc.
NTRA / Natera, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
ALBO / Albireo Pharma Inc
CCCC / C4 Therapeutics, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
KRON / Kronos Bio, Inc.
LPTX / Leap Therapeutics, Inc.
OM / Outset Medical, Inc.
LIANY / LianBio - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
US00847L2097 / AGILE THERAPEUTICS INC
RCUS / Arcus Biosciences, Inc.
SMFR / Sema4 Holdings Corp - Class A
HYPR / Hyperfine, Inc.
SRZN / Surrozen, Inc.
LSAQ / LifeSci Acquisition II Corp
PSTX / Poseida Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
US26886C1154 / EQRx Inc
CMAX / CareMax, Inc.
US62014P4054 / MOTUS GI HOLDINGS INC
/ Cytek Biosciences, Inc.
NVRO / Nevro Corp.
MORF / Morphic Holding, Inc.
RVMD / Revolution Medicines, Inc.
APLS / Apellis Pharmaceuticals, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
CMAXW / CareMax Inc - Warrants (08/06/2026)
HRMY / Harmony Biosciences Holdings, Inc.
NEPT / Neptune Wellness Solutions Inc.
COGT / Cogent Biosciences, Inc.
ISEE / IVERIC bio Inc
QTNT / Quotient Ltd
ALDX / Aldeyra Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
ABSI / Absci Corporation
CCXI / ChemoCentryx Inc
ZYME / Zymeworks Inc.
YMAB / Y-mAbs Therapeutics, Inc.
HCAT / Health Catalyst, Inc.
NARI / Inari Medical, Inc.
FULC / Fulcrum Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
NBTX / Nanobiotix S.A. - Depositary Receipt (Common Stock)
RAPT / RAPT Therapeutics, Inc.
AORT / Artivion, Inc.
SGEN / Seagen Inc
CTIC / CTI BioPharma Corp
PRTA / Prothena Corporation plc
TARA / Protara Therapeutics, Inc.
CLOV / Clover Health Investments, Corp.
HZNP / Horizon Therapeutics Plc
DICE / DICE Therapeutics Inc
PRVB / Provention Bio Inc
TCDA / Tricida Inc Put
RXDX / Prometheus Biosciences Inc
BMRN / BioMarin Pharmaceutical Inc.
DRIO / DarioHealth Corp.
ACRS / Aclaris Therapeutics, Inc.
ACLX / Arcellx, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ISRG / Intuitive Surgical, Inc.
ACRV / Acrivon Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
LABP / Landos Biopharma, Inc.
PEAR / Pear Therapeutics Inc - Class A
PNT / POINT Biopharma Global Inc.
OMIC / Singular Genomics Systems, Inc.
RLAY / Relay Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
MDGL / Madrigal Pharmaceuticals, Inc. Put
CHRS / Coherus Oncology, Inc.
TMCI / Treace Medical Concepts, Inc.
INBX.V / Inhibrx, Inc.
GBT / Global Blood Therapeutics Inc.
VRDN / Viridian Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
AKRO / Akero Therapeutics, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
IMVT / Immunovant, Inc.
ATNX / Athenex Inc
VBIV / VBI Vaccines Inc.
ATHA / Athira Pharma, Inc.
VERU / Veru Inc.
SLGC / Standard BioTools Inc.
SWTX / SpringWorks Therapeutics, Inc.
PRCT / PROCEPT BioRobotics Corporation
PYXS / Pyxis Oncology, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
TYRA / Tyra Biosciences, Inc.
NUVL / Nuvalent, Inc.
AXGN / Axogen, Inc.
NAUT / Nautilus Biotechnology, Inc.
MGTX / MeiraGTx Holdings plc